Outcomes based on age in the phase III METEOR trial of cabozantinib versus everolimus in patients with advanced renal cell carcinoma
在卡博替尼与依维莫司治疗晚期肾细胞癌患者的III期METEOR试验中,基于年龄的疗效结果
期刊:European Journal of Cancer
影响因子:7.1
doi:10.1016/j.ejca.2019.10.032
Donskov, Frede; Motzer, Robert J; Voog, Eric; Hovey, Elizabeth; Grüllich, Carsten; Nott, Louise M; Cuff, Katharine; Gil, Thierry; Jensen, Niels Viggo; Chevreau, Christine; Negrier, Sylvie; Depenbusch, Reinhard; Bergmann, Lothar; Cornelio, Izzy; Champsaur, Anne; Escudier, Bernard; Pal, Sumanta; Powles, Thomas; Choueiri, Toni K